Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 59: 959-968, 1985;
8750-7587/85 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaeffer, J. I.
Right arrow Articles by Haddad, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaeffer, J. I.
Right arrow Articles by Haddad, G. G.

Journal of Applied Physiology, Vol 59, Issue 3 959-968, Copyright © 1985 by American Physiological Society

ARTICLES

Regulation of ventilation and oxygen consumption by delta- and mu-opioid receptor agonists

J. I. Schaeffer and G. G. Haddad

To study the effect of endorphins on metabolic rate and on the relationship between O2 consumption (VO2) and ventilation, we administered enkephalin analogues (relatively selective delta-receptor agonists) and a morphiceptin analogue (a highly selective mu-receptor agonist) intracisternally in nine unanesthetized chronically instrumented adult dogs. Both delta- and mu-agonists decreased VO2 by 40-60%. delta-Agonists induced a dose-dependent decrease in mean instantaneous minute ventilation (VT/TT) associated with periodic breathing. The decrease in VT/TT started and resolved prior to the decrease and returned to baseline of VO2, respectively. In contrast, the mu-agonists induced an increase in VT/TT associated with rapid shallow breathing. Arterial PCO2 increased and arterial PO2 decreased after both delta- and mu-agonists. Low doses of intracisternal naloxone (0.002-2.0 micrograms/kg) reversed the opioid effect on VT/TT but not on VO2; higher doses of naloxone (5-25 micrograms/kg) reversed both. Naloxone administered alone had no effect on VT/TT or VO2. These data suggest that 1) both delta- and mu-agonists induce alveolar hypoventilation despite a decrease in VO2, 2) this hypoventilation results from a decrease in VT/TT after delta-agonists but an increase in dead space ventilation after mu-agonists, and 3) endorphins do not modulate ventilation and metabolic rate tonically, but we speculate that they may do so in response to stressful stimulation.


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
R. Romberg, E. Sarton, L. Teppema, H. W. D. Matthes, B. L. Kieffer, and A. Dahan
Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and {micro}-opioid receptor deficient mice
Br. J. Anaesth., December 1, 2003; 91(6): 862 - 870.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. Hilaire and B. Duron
Maturation of the Mammalian Respiratory System
Physiol Rev, April 1, 1999; 79(2): 325 - 360.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y.-F. Su, R. W. McNutt, and K.-J. Chang
Delta-Opioid Ligands Reverse Alfentanil-Induced Respiratory Depression but Not Antinociception
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 815 - 823.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online